BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 6531942)

  • 1. The pharmacokinetics of fentiazac and its metabolite, p-hydroxyfentiazac, after twice-daily oral administration to male volunteers.
    Dowell PS; Pierce DM; Franklin RA; Norris R; Harries H; Whiteland H
    Xenobiotica; 1984 Dec; 14(12):947-53. PubMed ID: 6531942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary studies on the fate of 14C-fentiazac in man.
    Franklin RA; Norris R; Shepherd NW; Rhenius ST
    Xenobiotica; 1984 Dec; 14(12):956-60. PubMed ID: 6531943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic study of fentiazac and its main metabolite hydroxyfentiazac in the elderly.
    Houin G; Lapeyre C; Rochas MA; Tufenkji AE; Campistron G; Coulais Y; Akbaraly JP; Grislain L; Beck H
    Arzneimittelforschung; 1993 Jan; 43(1):50-3. PubMed ID: 8447848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and urinary levels of fentiazac after a single oral and epicutaneous administration in human subjects.
    Quattrini M; Zanolo G; Mondino A; Giachetti C; Silvestri S
    Arzneimittelforschung; 1981; 31(6):1046-8. PubMed ID: 7196238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of fentiazac in rats and monkeys.
    Zanolo G; Giachetti C; Mondino A; Silvestri S; Bianchi E; Segre G; Gomarasca P; De Marchi G
    Arzneimittelforschung; 1981; 31(7):1098-104. PubMed ID: 7196759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of acipimox and of its N-deoxy metabolite following single and repeated oral administration to healthy volunteers.
    Efthymiopoulos C; Strolin Benedetti M; Poggesi I; Ruff F; Basileo G; Musatti L
    Therapie; 1993; 48(1):23-6. PubMed ID: 8356541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Topical action of fentiazac: skin absorption].
    Zanolo G; Giachetti C; Mondino A; Silvestri S; De Marchi G; Gomarasca P
    Boll Chim Farm; 1980 Apr; 119(4):209-20. PubMed ID: 7459043
    [No Abstract]   [Full Text] [Related]  

  • 8. Single and repeated dose pharmacokinetics of dexketoprofen trometamol in young and elderly subjects.
    Valles J; Artigas R; Bertolotti M; Crea A; Muller F; Paredes I; Capriati A
    Methods Find Exp Clin Pharmacol; 2006 Jun; 28 Suppl A():13-9. PubMed ID: 16801988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fentiazac in osteoarthritis: comparison of BID and QID regimens.
    Molina-López J
    Clin Ther; 1983; 5(5):462-71. PubMed ID: 6604579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects.
    Cilla DD; Whitfield LR; Gibson DM; Sedman AJ; Posvar EL
    Clin Pharmacol Ther; 1996 Dec; 60(6):687-95. PubMed ID: 8988072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of pentoxifylline and its 5-hydroxyhexyl metabolite after oral and intravenous administration of pentoxifylline to healthy adult horses.
    Liska DA; Akucewich LH; Marsella R; Maxwell LK; Barbara JE; Cole CA
    Am J Vet Res; 2006 Sep; 67(9):1621-7. PubMed ID: 16948611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
    Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxel.
    Britten CD; Baker SD; Denis LJ; Johnson T; Drengler R; Siu LL; Duchin K; Kuhn J; Rowinsky EK
    Clin Cancer Res; 2000 Sep; 6(9):3459-68. PubMed ID: 10999729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on skin diffusion with biological membranes: topical preparations of fentiazac acid].
    Leon MJ; Fauli C
    Boll Chim Farm; 1984 Nov; 123(11):512-20. PubMed ID: 6532479
    [No Abstract]   [Full Text] [Related]  

  • 17. Lormetazepam--plasma concentrations in volunteers following sublingual and oral dosing.
    Luscombe DK
    Psychopharmacology Suppl; 1984; 1():99-104. PubMed ID: 6147846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fentiazac as an oral analgesic for postoperative dental pain.
    Francisco JV
    Clin Ther; 1984; 6(6):787-92. PubMed ID: 6334555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of fentiazac.
    Fumero S; Mondino A; Silvestri S; Zanolo G; De Marchi G; Pedrazzini S
    Arzneimittelforschung; 1980; 30(8):1253-6. PubMed ID: 7192138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the antiinflammatory activity of fentiazac and its major metabolite, p-hydroxy fentiazac.
    Chang J; Carlson RP; Lewis AJ
    Agents Actions; 1984 Oct; 15(3-4):443-7. PubMed ID: 6441470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.